Bladder Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged 18 years or older, of any gender.
- People who have been diagnosed within the past 2 years with a specific type of bladder cancer called high-risk or very high-risk non-muscle-invasive urothelial carcinoma (a cancer that has not grown into the deeper muscle layers of the bladder and has not spread to other parts of the body), confirmed through laboratory testing of tissue samples, following a specific set of medical guidelines (EAU 2025). This also includes cases where this type of cancer makes up more than half of what was found in the tissue sample.
- People who, before joining the trial, have already had one of the following procedures: either a second surgical procedure to remove bladder tumour tissue (called a re-TURBT), or a complete initial removal of the bladder tumour where tissue samples — including the deep muscle layer of the bladder — showed no remaining cancer, all tested margins came back clear, and a urine test taken two weeks after surgery also came back clear.
Who may not be able to join:
- People who have been diagnosed with cancer in the upper parts of the urinary tract (such as the ureter or the kidney's drainage system) within the past 5 years, or who currently have that type of cancer at the same time as their bladder diagnosis.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +8613662096232
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Recurrence-Free Survival (RFS); Mean Number of Cystoscopic Examinations per Patient Within 2 Years
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.